Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PLAI-AF Trial: Hybrid Endo-epicardial Partial Left Atrial Isolation vs. Endocardial Ablation in Patients With Persistent Atrial Fibrillation

NCT05723536 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT05723536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05723536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PLAI-AF Trial: Hybrid Endo-epicardial Partial Left Atrial Isolation vs. Endocardial Ablation in Patients With Persistent Atrial Fibrillation
Lead sponsor
Hospital Clinic of Barcelona
Phase
Not applicable
Overall status
Recruiting
Start date
October 23, 2023
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia, atrial fibrillation, persistent atrial fibrillation